Tetavax, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv tetanusa, adsorbirano
| Name | Tetavax, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv tetanusa, adsorbirano |
|---|---|
| Marketing Authorisation Number | HR-H-943015948 |
| Active Substance | toksoid tetanusa |
| Composition | jedna doza (0,5 ml) sadrži: Toksoid tetanusa ≥ 40 IU adsorbiran na aluminijev hidroksid, hidrirani 0,6 mg Al |
| Pharmaceutical Form | suspenzija za injekciju u napunjenoj štrcaljki |
| Manufacturer | Sanofi-Aventis Zrt., Budimpešta, Mađarska Sanofi Pasteur, Lyon, Francuska |
| Marketing Authorisation Holder | Sanofi Pasteur, 14 Espace Henry Vallee, Lyon, Francuska |
| Marketing Authorisation Date | 20.09.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/638 |
| Registration Number | 381-12-01/30-19-10 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | J07AM01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
